Cargando…
Correction to: Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2—azithromycin trial
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933907/ https://www.ncbi.nlm.nih.gov/pubmed/33673831 http://dx.doi.org/10.1186/s13063-021-05153-4 |
| _version_ | 1783660715954929664 |
|---|---|
| author | Gyselinck, Iwein Liesenborghs, Laurens Landeloos, Ewout Belmans, Ann Verbeke, Geert Verhamme, Peter Vos, Robin Janssens, W. |
| author_facet | Gyselinck, Iwein Liesenborghs, Laurens Landeloos, Ewout Belmans, Ann Verbeke, Geert Verhamme, Peter Vos, Robin Janssens, W. |
| author_sort | Gyselinck, Iwein |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7933907 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79339072021-03-05 Correction to: Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2—azithromycin trial Gyselinck, Iwein Liesenborghs, Laurens Landeloos, Ewout Belmans, Ann Verbeke, Geert Verhamme, Peter Vos, Robin Janssens, W. Trials Correction BioMed Central 2021-03-05 /pmc/articles/PMC7933907/ /pubmed/33673831 http://dx.doi.org/10.1186/s13063-021-05153-4 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Gyselinck, Iwein Liesenborghs, Laurens Landeloos, Ewout Belmans, Ann Verbeke, Geert Verhamme, Peter Vos, Robin Janssens, W. Correction to: Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2—azithromycin trial |
| title | Correction to: Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2—azithromycin trial |
| title_full | Correction to: Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2—azithromycin trial |
| title_fullStr | Correction to: Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2—azithromycin trial |
| title_full_unstemmed | Correction to: Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2—azithromycin trial |
| title_short | Correction to: Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2—azithromycin trial |
| title_sort | correction to: direct antivirals working against the novel coronavirus: azithromycin (dawn-azithro), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against sars-cov-2—azithromycin trial |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933907/ https://www.ncbi.nlm.nih.gov/pubmed/33673831 http://dx.doi.org/10.1186/s13063-021-05153-4 |
| work_keys_str_mv | AT gyselinckiwein correctiontodirectantiviralsworkingagainstthenovelcoronavirusazithromycindawnazithroarandomizedmulticenteropenlabeladaptiveproofofconceptclinicaltrialofnewantiviralsworkingagainstsarscov2azithromycintrial AT liesenborghslaurens correctiontodirectantiviralsworkingagainstthenovelcoronavirusazithromycindawnazithroarandomizedmulticenteropenlabeladaptiveproofofconceptclinicaltrialofnewantiviralsworkingagainstsarscov2azithromycintrial AT landeloosewout correctiontodirectantiviralsworkingagainstthenovelcoronavirusazithromycindawnazithroarandomizedmulticenteropenlabeladaptiveproofofconceptclinicaltrialofnewantiviralsworkingagainstsarscov2azithromycintrial AT belmansann correctiontodirectantiviralsworkingagainstthenovelcoronavirusazithromycindawnazithroarandomizedmulticenteropenlabeladaptiveproofofconceptclinicaltrialofnewantiviralsworkingagainstsarscov2azithromycintrial AT verbekegeert correctiontodirectantiviralsworkingagainstthenovelcoronavirusazithromycindawnazithroarandomizedmulticenteropenlabeladaptiveproofofconceptclinicaltrialofnewantiviralsworkingagainstsarscov2azithromycintrial AT verhammepeter correctiontodirectantiviralsworkingagainstthenovelcoronavirusazithromycindawnazithroarandomizedmulticenteropenlabeladaptiveproofofconceptclinicaltrialofnewantiviralsworkingagainstsarscov2azithromycintrial AT vosrobin correctiontodirectantiviralsworkingagainstthenovelcoronavirusazithromycindawnazithroarandomizedmulticenteropenlabeladaptiveproofofconceptclinicaltrialofnewantiviralsworkingagainstsarscov2azithromycintrial AT janssensw correctiontodirectantiviralsworkingagainstthenovelcoronavirusazithromycindawnazithroarandomizedmulticenteropenlabeladaptiveproofofconceptclinicaltrialofnewantiviralsworkingagainstsarscov2azithromycintrial AT correctiontodirectantiviralsworkingagainstthenovelcoronavirusazithromycindawnazithroarandomizedmulticenteropenlabeladaptiveproofofconceptclinicaltrialofnewantiviralsworkingagainstsarscov2azithromycintrial |